{"id":410148,"date":"2021-01-07T07:03:10","date_gmt":"2021-01-07T12:03:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=410148"},"modified":"2021-01-07T07:03:10","modified_gmt":"2021-01-07T12:03:10","slug":"trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/","title":{"rendered":"Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences"},"content":{"rendered":"
\n

CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN)<\/strong>, a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that management will participate in two upcoming virtual investor conferences, with additional details below.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u00a0<\/td>\n\u00a0<\/td>\n\n
\n LifeSci Partners 10th Annual Healthcare Corporate Access Event<\/strong>
\n <\/em>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Date:<\/strong>\n <\/td>\nFriday, January 8th<\/sup>, 2021<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Time:<\/strong>\n <\/td>\n2:00 p.m. ET<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Format:<\/strong>\n <\/td>\nPanel Discussion – Executing a Successful Product Launch During a Pandemic<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Attendees:<\/strong>\n <\/td>\nCarrie Bourdow,\u00a0President & CEO<\/em><\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Webcast<\/strong>
\n :<\/strong>\n <\/td>\n		\n https:\/\/wsw.com\/webcast\/lifesci\/panel14\/2387307<\/a>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\n
\n H.C. Wainwright BioConnect Conference<\/strong>
\n <\/em>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Date:<\/strong>\n <\/td>\nMonday, January 11th<\/sup>, 2021<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Time:\u00a0<\/strong>\n <\/td>\n6:00 a.m. ET (webcast available)<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Format:<\/strong>\n <\/td>\nFireside Chat<\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Attendees:<\/strong>\n <\/td>\nCarrie Bourdow,\u00a0President & CEO<\/em><\/td>\n<\/tr>\n
\u00a0<\/td>\n\n \u00a0<\/strong>\n <\/td>\nBob Yoder, Senior Vice President & Chief Commercial Officer<\/em><\/td>\n<\/tr>\n
\u00a0<\/td>\n\n Webcast:<\/strong>\n <\/td>\n\n https:\/\/journey.ct.events\/view\/940f6f19-b43a-471d-8bab-6aa4e8e612e0<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

Links to the webcasts will be available on the Events page of the Investors section on the Company\u2019s website at www.trevena.com\/investors\/events-presentations\/ir-calendar<\/a>.<\/p>\n

\n About Trevena<\/strong>\n <\/p>\n

Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with CNS disorders. The Company has one approved product in the U.S., OLINVYK\u2122 (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The Company also has four novel and differentiated investigational drug candidates: TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, and TRV027 for acute lung injury \/ abnormal blood clotting in COVID-19 patients. The Company has also identified TRV045, a novel S1P receptor modulator that may offer a new, non-opioid approach to treating a variety of CNS disorders.<\/p>\n

For more information, please visit\u00a0www.Trevena.com<\/a>.<\/p>\n

\n Forward-Looking Statements<\/strong>\n <\/p>\n

Any statements in this press release about future expectations, plans and prospects for the Company, including statements about the Company\u2019s strategy, future operations, clinical development and trials of its therapeutic candidates, plans for potential future product candidates, commercialization of approved drug products and other statements containing the words \u201canticipate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cobjective,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201csuggest,\u201d \u201ctarget,\u201d \u201cpotential,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201ccontinue,\u201d \u201congoing,\u201d or the negative of these terms or similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the commercialization of any approved drug product, the status, timing, costs, results and interpretation of the Company\u2019s clinical trials or any future trials of any of the Company\u2019s investigational drug candidates; the uncertainties inherent in conducting clinical trials; expectations for regulatory interactions, submissions and approvals, including the Company\u2019s assessment of the discussions with the FDA or other regulatory agencies about any and all of its programs; uncertainties related to the commercialization of OLINVYK; available funding; uncertainties related to the Company\u2019s intellectual property; uncertainties related to the ongoing COVID-19 pandemic, other matters that could affect the availability or commercial potential of the Company\u2019s therapeutic candidates; and other factors discussed in the Risk Factors set forth in the Company\u2019s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission (SEC) and in other filings the Company makes with the SEC from time to time. In addition, the forward-looking statements included in this press release represent the Company\u2019s views only as of the date hereof. The Company anticipates that subsequent events and developments may cause the Company\u2019s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so, except as may be required by law.<\/p>\n

\n For more information, please contact:<\/strong>\n <\/p>\n

\n Investor Contact:<\/strong>
\n
Dan Ferry
Managing Director
LifeSci Advisors, LLC
daniel@lifesciadvisors.com
<\/a>(617) 430-7576<\/p>\n

\n Company Contact:<\/strong>
\n
Bob Yoder
SVP and Chief Commercial Officer
Trevena, Inc.
(610) 354-8840<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that management will participate in two upcoming virtual investor conferences, with additional details below. \u00a0 \u00a0 LifeSci Partners 10th Annual Healthcare Corporate Access Event \u00a0 Date: Friday, January 8th, 2021 \u00a0 Time: 2:00 p.m. ET \u00a0 Format: Panel Discussion – Executing a Successful Product Launch During a Pandemic \u00a0 Attendees: Carrie Bourdow,\u00a0President & CEO \u00a0 Webcast : https:\/\/wsw.com\/webcast\/lifesci\/panel14\/2387307 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 H.C. Wainwright BioConnect Conference \u00a0 Date: Monday, January 11th, 2021 \u00a0 Time:\u00a0 6:00 a.m. ET (webcast available) \u00a0 Format: Fireside Chat \u00a0 Attendees: … <\/p>\n

Continue reading “Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-410148","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTrevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that management will participate in two upcoming virtual investor conferences, with additional details below. \u00a0 \u00a0 LifeSci Partners 10th Annual Healthcare Corporate Access Event \u00a0 Date: Friday, January 8th, 2021 \u00a0 Time: 2:00 p.m. ET \u00a0 Format: Panel Discussion – Executing a Successful Product Launch During a Pandemic \u00a0 Attendees: Carrie Bourdow,\u00a0President & CEO \u00a0 Webcast : https:\/\/wsw.com\/webcast\/lifesci\/panel14\/2387307 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 H.C. Wainwright BioConnect Conference \u00a0 Date: Monday, January 11th, 2021 \u00a0 Time:\u00a0 6:00 a.m. ET (webcast available) \u00a0 Format: Fireside Chat \u00a0 Attendees: … Continue reading "Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-07T12:03:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1OCMzOTA4MzI2IzIwMDUwMzQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences\",\"datePublished\":\"2021-01-07T12:03:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/\"},\"wordCount\":669,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTk1OCMzOTA4MzI2IzIwMDUwMzQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/\",\"name\":\"Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTk1OCMzOTA4MzI2IzIwMDUwMzQ=\",\"datePublished\":\"2021-01-07T12:03:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTk1OCMzOTA4MzI2IzIwMDUwMzQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTk1OCMzOTA4MzI2IzIwMDUwMzQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences - Market Newsdesk","og_description":"CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that management will participate in two upcoming virtual investor conferences, with additional details below. \u00a0 \u00a0 LifeSci Partners 10th Annual Healthcare Corporate Access Event \u00a0 Date: Friday, January 8th, 2021 \u00a0 Time: 2:00 p.m. ET \u00a0 Format: Panel Discussion – Executing a Successful Product Launch During a Pandemic \u00a0 Attendees: Carrie Bourdow,\u00a0President & CEO \u00a0 Webcast : https:\/\/wsw.com\/webcast\/lifesci\/panel14\/2387307 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 H.C. Wainwright BioConnect Conference \u00a0 Date: Monday, January 11th, 2021 \u00a0 Time:\u00a0 6:00 a.m. ET (webcast available) \u00a0 Format: Fireside Chat \u00a0 Attendees: … Continue reading \"Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-07T12:03:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1OCMzOTA4MzI2IzIwMDUwMzQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences","datePublished":"2021-01-07T12:03:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/"},"wordCount":669,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1OCMzOTA4MzI2IzIwMDUwMzQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/","name":"Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1OCMzOTA4MzI2IzIwMDUwMzQ=","datePublished":"2021-01-07T12:03:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1OCMzOTA4MzI2IzIwMDUwMzQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1OCMzOTA4MzI2IzIwMDUwMzQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/trevena-inc-to-participate-in-two-upcoming-virtual-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=410148"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410148\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=410148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=410148"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=410148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}